Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus.
Eric F MorandGabriel AbreuRichard A FurieVera GolderRaj TummalaPublished in: Annals of the rheumatic diseases (2023)
NCT02446912 and NCT02446899.